SAMSARA BIOCAPITAL, LLC
Position in RANI — Rani Therapeutics Holdings, Inc.
CIK 1744967
PALO ALTO, CA
Position in RANI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,880,560
+$1,633,060 QoQ
Shares Held
10,369,159
+22.0% QoQ
Ownership
7.44%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1
of 67 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RANI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SAMSARA BIOCAPITAL, LLC holds $1,139,869,255 across 22 Biotechnology names. RANI ranks #15 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
6,897,652 | $379,370,860 | |
| 2 | ALMS |
Alumis Inc.
|
6,345,219 | $178,554,462 | |
| 3 | MLYS |
Mineralys Therapeutics, Inc.
|
5,871,018 | $158,400,065 | |
| 4 | SEPN |
Septerna, Inc.
|
3,149,128 | $105,464,296 | |
| 5 | NGNE |
Neurogene Inc.
|
1,717,127 | $54,003,644 | |
| 6 | KLRS |
Kalaris Therapeutics, Inc.
|
12,881,175 | $52,426,382 | |
| 7 | SGP |
SpyGlass Pharma, Inc.
|
2,109,953 | $46,967,553 | |
| 8 | STRO |
Sutro Biopharma, Inc.
|
1,062,872 | $35,287,350 |
All Filings in RANI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,880,560 | 10,369,159 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,247,500 | 8,500,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,475,000 | 8,500,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||